In our study we demonstrate the expression of BAMBI in www.selleckchem.com/products/baricitinib-ly3009104.html the human lung with a clearly membranous expression pattern. Signaling of TGF B is known to be mediated via the TGF receptors I and II which may be prevented by interaction of the cytokine with the pseudoreceptor. This mechanism may influ ence TGF signalling besides other known activation and signalling pathways. Both in vivo and acute in vitro NTHI infection were associated with marked upreg ulation of BAMBI. Since TGF B is a central mediator of tissue rermodeling pathogen induced expression of BAMBI may contribute to impaired tissue repair in COPD. Interestingly NTHI infection of lung tissue and alveolar epithelial cells led to a decreased release of TGF B which to our knowledge has not been described up to now.
This imbalance between expression of pseudorecep tor and cytokine could play a crucial role in TGF B effec tor function and may be explained by the binding of TGF B on BAMBI. In contrast, no significant alteration of TGF receptors I and II in response to NTHI infection was demonstrated. Taken together we speculate that in the lung BAMBI may serve as an inhibitor of excessive TGF B spillover which could be deleterious for the parenchyma by inducing profibrotic activity. Smoking may also influence TGF signalling impor tantly. Acute smoke exposure generates increased TGF beta levels in animal models which may be due to downregulation of BAMBI induced by LPS from tobacco smoke. In contrast chronic LPS exposure is associ ated with hyporesponsiveness.
This mechanism could explain increased BAMBI expression in chronic smokers with COPD leading to progression of destruc tion of lung parenchyma. The relative contribution of chronic smoking and or bacterial infection awaits further study since we were not able to evaluate lung tissue from healthy smokers. In addition the presence of mediators released by malignant cells or effects of steroid treatment in the lung tissues analyzed here may also have influenced our find ings. However, the fact that cell culture experiments using A549 cells generated similar results makes this pos sibility unlikely. Bacterial infections are a major cause of exacerbations with NTHI being the most frequent pathogen isolated. We have shown that NTHI is expressed intracellu larly in 38% of COPD lungs from patients without evi dence for acute exacerbation corresponding to data from a previous study reporting a detection rate of 50% in a group of COPD patients undergoing lung transplantation.
We observed that acute in vitro NTHI infection leads to a strong proinflammatory cytokine expression, but a reduced expression of TGF B. Considering the immunosuppressive Carfilzomib properties of TGF B impaired TGF signalling may contribute to the increased pathogen induced inflammatory response in COPD. On the other hand this imbalance carries the risk of tissue destruction.